Key measurements of U.S. CDER drug approvals in 2023

This statistic depicts the percentage of drugs approved by the U.S. Center for Drug Evaluation and Research (CDER) in 2023 that met select key measures. According to the data, 89 percent of all drugs approved in 2023 by CDER met the PDUFA goal date for approval, and 51 percent of approved drugs were drugs for orphan diseases.

本统计数据显示了2023年由美国食品药品监督管理局（CDER）批准的药品中，符合选定关键指标的百分比。根据数据，2023年由CDER批准的所有药品中，有89%在PDUFA目标批准日期前获得批准，且51%的批准药品针对的是罕见病药物。